Literature DB >> 18205793

Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.

Toshihiro Sawai1, Yasushi Itoh, Hiroichi Ozaki, Norikazu Isoda, Kiyoko Okamoto, Yoshitaka Kashima, Yoshihiro Kawaoka, Yoshihiro Takeuchi, Hiroshi Kida, Kazumasa Ogasawara.   

Abstract

We investigated whether a vaccine derived from an apathogenic reassortant type A H5N1 influenza strain could induce immune responses in vivo that mediated protection from highly pathogenic avian influenza virus infection in mice. After two subcutaneous immunizations with formalin-inactivated H5N1 whole virus particles (whole particle vaccine), significant killing specific for cells presenting a nucleoprotein peptide from the vaccine strain of the virus was observed. Similar vaccination with viruses treated with ether and formalin, which are commonly used for humans as ether-split vaccines, induced little or no cytotoxic T-cell response. Furthermore, whole particle vaccines of the apathogenic H5N1 strain were more effective than ether-split vaccines at inducing antibody production able to neutralize a highly pathogenic H5N1 strain. Finally, whole particle vaccines of H5N1 protected mice against infection by an H5N1 highly pathogenic avian influenza virus more effectively than did ether-split vaccines. These results suggest that formalin-inactivated virus particles of apathogenic strains are effective for induction of both cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza viruses in vivo, resulting in protection from infection by a highly pathogenic H5N1 virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205793      PMCID: PMC2566620          DOI: 10.1111/j.1365-2567.2007.02745.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.

Authors:  D Nelson; C Bundell; B Robinson
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

2.  Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice.

Authors:  Gabrielle T Belz; Dominik Wodarz; Gabriela Diaz; Martin A Nowak; Peter C Doherty
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.

Authors:  Ai Ninomiya; Kazumasa Ogasawara; Kiichi Kajino; Ayato Takada; Hiroshi Kida
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

4.  Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Authors:  J Tian; D Zekzer; L Hanssen; Y Lu; A Olcott; D L Kaufman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

5.  Autophagy-dependent viral recognition by plasmacytoid dendritic cells.

Authors:  Heung Kyu Lee; Jennifer M Lund; Balaji Ramanathan; Noboru Mizushima; Akiko Iwasaki
Journal:  Science       Date:  2007-02-01       Impact factor: 47.728

6.  Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/7/04 (H5N1) in different species of birds and mammals.

Authors:  N Isoda; Y Sakoda; N Kishida; G-R Bai; K Matsuda; T Umemura; H Kida
Journal:  Arch Virol       Date:  2006-02-26       Impact factor: 2.574

7.  Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses.

Authors:  V Blazevic; C M Trubey; G M Shearer
Journal:  Hum Immunol       Date:  2000-09       Impact factor: 2.850

8.  Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus.

Authors:  Z Sha; R W Compans
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon.

Authors:  Sang Heui Seo; Malik Peiris; Robert G Webster
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model.

Authors:  Enrico Proietti; Laura Bracci; Simona Puzelli; Tiziana Di Pucchio; Paola Sestili; Enrico De Vincenzi; Massimo Venditti; Imerio Capone; Isabelle Seif; Edward De Maeyer; David Tough; Isabella Donatelli; Filippo Belardelli
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

View more
  11 in total

1.  Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.

Authors:  Yasushi Itoh; Shintaro Shichinohe; Misako Nakayama; Manabu Igarashi; Akihiro Ishii; Hirohito Ishigaki; Hideaki Ishida; Naoko Kitagawa; Takako Sasamura; Masanori Shiohara; Michiko Doi; Hideaki Tsuchiya; Shinichiro Nakamura; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Kazumasa Ogasawara
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

2.  Controlling influenza by cytotoxic T-cells: calling for help from destroyers.

Authors:  Michael Schotsaert; Lorena Itatí Ibañez; Walter Fiers; Xavier Saelens
Journal:  J Biomed Biotechnol       Date:  2010-05-24

3.  Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration.

Authors:  Niels Hagenaars; Enrico Mastrobattista; Rolf J Verheul; Imke Mooren; Harrie L Glansbeek; Jacco G M Heldens; Han van den Bosch; Wim Jiskoot
Journal:  Pharm Res       Date:  2009-02-18       Impact factor: 4.200

4.  An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.

Authors:  Ahmad M Haredy; Nobuyuki Takenaka; Hiroshi Yamada; Yoshihiro Sakoda; Masatoshi Okamatsu; Naoki Yamamoto; Takeshi Omasa; Hisao Ohtake; Yasuko Mori; Hiroshi Kida; Koichi Yamanishi; Shigefumi Okamoto
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

5.  Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine.

Authors:  Natalija Budimir; Aalzen de Haan; Tjarko Meijerhof; Simke Waijer; Louis Boon; Emma Gostick; David A Price; Jan Wilschut; Anke Huckriede
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

6.  Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice.

Authors:  Qiang Zou; Yanxin Hu; Jia Xue; Xiaoxu Fan; Yi Jin; Xianghua Shi; Di Meng; Xianzheng Wang; Congcong Feng; Xiaoping Xie; Yizhi Zhang; Youmin Kang; Xiaoxuan Liang; Bing Wu; Ming Wang; Bin Wang
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

7.  Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02.

Authors:  Masahiko Arikata; Yasushi Itoh; Masatoshi Okamatsu; Toshinaga Maeda; Takashi Shiina; Keiko Tanaka; Shingo Suzuki; Misako Nakayama; Yoshihiro Sakoda; Hirohito Ishigaki; Ayato Takada; Hideaki Ishida; Kosuke Soda; Van Loi Pham; Hideaki Tsuchiya; Shinichiro Nakamura; Ryuzo Torii; Takeshi Shimizu; Hidetoshi Inoko; Iwao Ohkubo; Hiroshi Kida; Kazumasa Ogasawara
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 8.  Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals.

Authors:  Kayode Komolafe; Titilope Ruth Komolafe; Toluwase Hezekiah Fatoki; Afolabi Clement Akinmoladun; Bartholomew I C Brai; Mary Tolulope Olaleye; Afolabi Akintunde Akindahunsi
Journal:  Rev Bras Farmacogn       Date:  2021-03-11       Impact factor: 2.464

Review 9.  Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review.

Authors:  Gaber El-Saber Batiha; Amany Magdy Beshbishy; Lamiaa G Wasef; Yaser H A Elewa; Ahmed A Al-Sagan; Mohamed E Abd El-Hack; Ayman E Taha; Yasmina M Abd-Elhakim; Hari Prasad Devkota
Journal:  Nutrients       Date:  2020-03-24       Impact factor: 5.717

10.  Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization.

Authors:  Eita Sasaki; Hideki Asanuma; Haruka Momose; Keiko Furuhata; Takuo Mizukami; Isao Hamaguchi
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.